Some employees have new work spaces after Amgen spent $200 million renovating and upgrading its Thousand Oaks campus. (Marissa Nall photo) Investments at its flagship facilities in Thousand Oaks mark a strategic shift for Amgen when it comes to choosing which diseases the biotech giant tackles. With the infusion of $200 million in capital,…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
